The present study investigated the protective effects of
leucine against
lipopolysaccharide (LPS)-induced inflammatory responses in Labeo rohita (rohu) in vivo and in vitro. Primary hepatocytes, isolated from the hepatopancreas, were exposed to different concentrations of LPS for 24 h to induce an inflammatory response, and the protective effects of
leucine against LPS-induced
inflammation were studied. Finally, we investigated the efficiency of dietary
leucine supplementation in attenuating an immune challenge induced by LPS in vivo. Exposure of cells to 10-25 μg mL(-1) of LPS for 24 h resulted in a significant production of
nitric oxide and release of
lactate dehydrogenase to the medium, whereas cell viability and
protein content were reduced (p < 0.05). LPS exposure (10 μg mL(-1)) increased
mRNA levels of the pro-inflammatory
cytokines TNF-α, IL-1β and
IL-8 in vitro (p < 0.05). However, pretreatment with
leucine prevented the LPS-induced upregulation of TNF-α, IL-1β and
IL-8 mRNAs by downregulating TLR4, MyD88, NF-κBp65, and MAPKp38
mRNA expression. Interestingly,
mRNA expression of the anti-inflammatory
cytokine,
IL-10, which was increased by LPS treatment, was further enhanced (p < 0.05) by
leucine pretreatment. The enhanced expression of
IL-10 might inhibit the production of other pro-inflammatory
cytokines. It was found that
leucine pretreatment attenuated the excessive activation of LPS-induced TLR4-MyD88 signaling as manifested by lower level of TLR4, MyD88, MAPKp38, NF-κBp65 and increased level of IκB-α
protein in
leucine pre-treatment group. In vivo experiments demonstrated that
leucine pre-supplementation could protect fish against LPS-induced
inflammation through an attenuation of TLR4-MyD88 signaling pathway. Taken together, we propose that
leucine pre-supplementation decreases LPS-induced immune damage in rohu by enhancing the expression of
IL-10 and by regulating the TLR4-MyD88 signaling pathways.